Marcello Maggiolini

Papers

Total Citations

H-Index

About

Marcello Maggiolini is a leading figure in the field of medicinal chemistry, with a primary focus on the rational design of novel selective estrogen receptor modulators (SERMs). His work bridges structural biology and drug discovery, leveraging protein crystallography to develop targeted therapies for hormone-dependent conditions. Maggiolini’s seminal 2011 paper, “Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators,” has garnered 15 citations, reflecting its foundational role in advancing structure-guided drug design. This research exemplifies his commitment to translating three-dimensional protein structures into actionable insights for optimizing drug efficacy and selectivity. Beyond this key contribution, Maggiolini has been instrumental in exploring how high-throughput crystallographic techniques can accelerate the identification of lead compounds, a methodology that has influenced subsequent studies in endocrine pharmacology. His achievements underscore a career dedicated to bridging computational and experimental approaches, making him a respected voice in the development of next-generation therapeutics for estrogen receptor-related diseases. Students and researchers in drug discovery will find his work a model of how structural insights can drive innovation in medicinal chemistry.